WM S2
Alternative Names: WM-S2Latest Information Update: 28 Apr 2024
Price :
$50 *
At a glance
- Originator Well Marker Bio
- Developer Wellmarker Bio
- Class Antineoplastics; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Prostate cancer; Solid tumours
- No development reported Colorectal cancer
Most Recent Events
- 28 Apr 2024 No recent reports of development identified for preclinical development in Colorectal-cancer in South Korea
- 10 Mar 2021 Early research in Prostate cancer in South Korea (unspecified route) (Wellmarker Bio pipeline, March 2021)
- 10 Mar 2021 Early research in Solid tumours in South Korea (unspecified route) (Wellmarker Bio pipeline, March 2021)